Australia markets open in 4 hours 21 minutes

Bora Pharmaceuticals Co., LTD. (6472.TW)

Taiwan - Taiwan Delayed price. Currency in TWD
Add to watchlist
876.00+14.00 (+1.62%)
At close: 01:30PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 88.19B
Enterprise value 88.84B
Trailing P/E 33.68
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.45
Price/book (mrq)10.15
Enterprise value/revenue 7.24
Enterprise value/EBITDA 20.06

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 341.29%
S&P500 52-week change 326.25%
52-week high 3895.00
52-week low 3612.00
50-day moving average 3771.68
200-day moving average 3707.22

Share statistics

Avg vol (3-month) 32.87M
Avg vol (10-day) 32.94M
Shares outstanding 5100.67M
Implied shares outstanding 6101.19M
Float 856.61M
% held by insiders 145.44%
% held by institutions 19.57%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 46.16
Forward annual dividend yield 40.70%
Trailing annual dividend rate 312.00
Trailing annual dividend yield 31.39%
5-year average dividend yield 41.19
Payout ratio 423.68%
Dividend date 3N/A
Ex-dividend date 406 July 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 22.05%
Operating margin (ttm)31.22%

Management effectiveness

Return on assets (ttm)10.74%
Return on equity (ttm)31.61%

Income statement

Revenue (ttm)12.28B
Revenue per share (ttm)121.72
Quarterly revenue growth (yoy)-40.20%
Gross profit (ttm)N/A
EBITDA 5.13B
Net income avi to common (ttm)2.71B
Diluted EPS (ttm)26.02
Quarterly earnings growth (yoy)-31.10%

Balance sheet

Total cash (mrq)8.39B
Total cash per share (mrq)83
Total debt (mrq)9.04B
Total debt/equity (mrq)78.93%
Current ratio (mrq)1.21
Book value per share (mrq)85.94

Cash flow statement

Operating cash flow (ttm)3.87B
Levered free cash flow (ttm)2.9B